Frequent factor II G20210A mutation in idiopathic portal vein thrombosis

Gastroenterology

Volumn 116, Issue 1, 1999, Pages 144-148

  Chamouard, P ^a   Pencreach, E ^a   Maloisel, F ^a   Grunebaum, L ^a   Ardizzone, J F ^a   Meyer, A ^a   Gaub, M P ^a   Goetz, J ^a   Baumann, R ^a   Uring Lambert, B ^a   Levy, S ^a   Dufour, P ^a   Hauptmann, G ^a   Oudet, P ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; IDIOPATHIC DISEASE; MALE; PARTIAL THROMBOPLASTIN TIME; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL;

EID: 0032923710     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70238-6     Document Type: Article

References (26)

1. LJ Webb S. Sherlock The etiology, presentation and natural history of extra-hepatic portal venous obstruction QJM 192 1979 627 639
2. D Valla N Casadevall MG Huisse M Tuillez JD Grange O Muller T Binda B Varet B Rueff JP. Benhamou Etiology of portal vein thrombosis in adults: a prospective evaluation of primary myeloproliferative disorders Gastroenterology 94 1988 1063 1069
3. JA Grossman WV. McDermott Paroxysmal nocturnal hemoglobinuria associated with hepatic and portal venous thrombosis Am J Surg 127 1974 733 746
4. R Maung JK Kelly MP Schneider MC. Poon Mesenteric venous thrombosis due to antithrombin III deficiency Arch Pathol Lab Med 112 1988 37 39
5. D Valla MH Denninger JM Delvigne B Rueff JO. Benhamou Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency Gut 29 1988 856 859
6. F Prat D Ouzan N Trecziak C. Trepo Portal and mesenteric thrombosis revealing constitutional protein C deficiency Gut 30 1989 416 421
7. G Sas G Blasko I Petr JH. Griffin A protein S deficient family with portal vein thrombosis Thromb Haemost 54 1985 724 729
8. F Cardot JY Borg C Guédon E Lerebours R. Colin Les syndromes d'ischiémie veineuse mésentérique: infarctus et ischiémie transitoire Gastroenterol Clin Biol 16 1992 644 648
9. RY Rhee P Gloviczki CT Mendonca TM Petterson RD Serry MG Sarr CM Johnson TC Bower JW Hallett KJ. Cherry Mesenteric venous thrombosis: still a lethal disease in the 1990s J Vasc Surg 20 1994 688 697
10. B Dahlbäck M Carlsson PJ. Svensson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci USA 90 1993 1004 1008
11. RM Bertina RPC Koeleman T Koster FR Rosendaal RJ Dirven H De Ronde PA Van Der Velden PH. Reistma Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
12. B Zöller B. Dahlbäck Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis Lancet 343 1994 1536 1538
13. SR Poort FR Rosendaal PH Reitsma RM. Bertina A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
14. JI Jorquera JM Montoro MA Fernandez JA Aznar J. Aznar Modified test for activated protein C resistance Lancet 344 1994 1162 1163
15. A Bezeaud L Drouet C Soria MC. Guillin Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin Thromb Res 34 1984 507 518
16. F Soubrier I Fery E Verdy MN Rene B Varsat S Visvikis G. Siest The frequency of the factor V gene R506Q mutation varies between regions of France N Rev Fr Hematol 37 1995 175
17. AEA Mahmoud E Elias N Beauchamp JT. Wilde Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis Gut 40 1997 798 800
18. MH Denninger D Helley D Valla MC. Guillin Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis Thromb Haemost 78 1997 1297 1298
19. FR. Rosendaal Risk factors for venous thrombosis: prevalence, risk, and interaction Semin Hematol 34 1997 171 187
20. NI. Berlin Polycythemia vera: an update Semin Hematol 23 1986 131 143
21. G Barosi A Buratti A Costa LN Liberato C Balduini M Cazzola V Rosti U Magrini E. Ascari An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression Cancer 68 1991 2310 2318
22. L Teofili V De Stephano G Leone P Micalizzi MS Iovono G Alfano B. Bizzi Hematological causes of venous thrombosis in young people: high incidence of myeloproliferative disorder as underlying disease in patients with splanchnic venous thrombosis Thromb Haemost 67 1992 297 301
23. A Pagliuca GJ Mufti M Janossa S Eridani NB Westwood J Thumpston B Sawyer R Sturgess R. Williams In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis: possible evidence of an occult myeloproliferative state QJM 76 1990 981 989
24. D Valla MH Denninger N Casadevall Y Chaït S Hillaire MC Guillin S Erlinger J. Brière Thrombose de la veine porte et des veines hépatiques: combinaisons d'affections thrombogènes multiples et de facteurs locaux (abstr) Gastroenterol Clin Biol 21 1997 731
25. D Williamson K Brown R Luddington C Baglin T. Baglin Factor V Cambridge: a new mutation (Arg306 → Thr) associated with resistance to activated protein C Blood 91 1998 1140 1144
26. V De Stephano P Chiusolo K Paciaroni I Casorelli E Rossi M Molinari S Servidei PA Tonali G. Leone Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients Blood 91 1998 3562 3565